Position in BBIO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$23,962,958
New position
Shares Held
322,690
first reported quarter
Ownership
0.165%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 36%
Shared 2%
None 62%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fiera Capital Corp holds $821,046,758 across 19 Biotechnology names. BBIO ranks #12 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
1,021,970 | $167,112,534 | |
| 2 | ARGX |
Argenx SE
|
217,198 | $158,608,839 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
174,011 | $91,089,537 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
2,527,076 | $84,202,171 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
709,529 | $41,259,110 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
711,326 | $37,501,106 | |
| 7 | IMCR |
Immunocore Holdings plc
|
1,080,099 | $32,564,984 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
135,312 | $27,015,040 |
All Filings in BBIO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,962,958 | 322,690 | Shares | Other | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||